Group in figures
Fresenius is a global healthcare company. Comitted to life – the health and well-being of patients is Fresenius’ top priority. For more than 100 years, we have been combining cutting-edge technology with a focus on patients, paving the way for the therapies of the future. We save and improve lives and health. We provide access to affordable and innovative medical products and clinical care of the highest quality.
€ in millions |
|
2024 |
|
2023 |
|
2022 |
|
2021 |
|
2020 |
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and earnings |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Revenue1 |
|
21,526 |
|
20,307 |
|
21,532 |
|
19,969 |
|
18,476 |
||||||||||||||||||
|
3,614 |
|
3,319 |
|
3,315 |
|
3,353 |
|
3,042 |
|||||||||||||||||||
|
2,489 |
|
2,266 |
|
2,190 |
|
2,337 |
|
2,113 |
|||||||||||||||||||
|
1,749 |
|
1,543 |
|
1,729 |
|
1,867 |
|
1,796 |
|||||||||||||||||||
|
1,125 |
|
1,145 |
|
1,125 |
|
1,016 |
|
929 |
|||||||||||||||||||
|
3.11 |
|
2.74 |
|
3.08 |
|
3.35 |
|
3.22 |
|||||||||||||||||||
Cash flow and balance sheet |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Operating cash flow1 |
|
2,447 |
|
2,131 |
|
2,031 |
|
2,589 |
|
2,316 |
||||||||||||||||||
Free cash flow before acquisitions, dividends and lease liabilities1 |
|
1,623 |
|
1,130 |
|
942 |
|
1,401 |
|
986 |
||||||||||||||||||
Free cash flow after acquisitions, dividends and lease liabilities1 |
|
1,730 |
|
188 |
|
-318 |
|
388 |
|
18 |
||||||||||||||||||
Cash conversion rate1 |
|
1.0 |
|
1.0 |
|
0.9 |
|
0.9 |
|
0.8 |
||||||||||||||||||
Total assets |
|
43,550 |
|
45,284 |
|
76,400 |
|
71,962 |
|
66,646 |
||||||||||||||||||
Non-current assets |
|
32,104 |
|
32,764 |
|
58,121 |
|
54,501 |
|
50,874 |
||||||||||||||||||
Equity4 |
|
20,290 |
|
19,651 |
|
32,218 |
|
29,288 |
|
26,023 |
||||||||||||||||||
Equity ratio4 |
|
47% |
|
43% |
|
42% |
|
41% |
|
39% |
||||||||||||||||||
Net debt1 |
|
11,295 |
|
13,268 |
|
13,316 |
|
12,650 |
|
13,021 |
||||||||||||||||||
|
3.0 |
|
3.8 |
|
3.8 |
|
3.6 |
|
4.1 |
|||||||||||||||||||
|
1,035 |
|
1,346 |
|
2,015 |
|
1,635 |
|
1,841 |
|||||||||||||||||||
Profitability |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
11.6% |
|
11.2% |
|
10.2% |
|
11.7% |
|
11.4% |
|||||||||||||||||||
|
6.2% |
|
5.2% |
|
5.6% |
|
6.2% |
|
5.9% |
|||||||||||||||||||
Dividend per share in € |
|
1.007 |
|
– |
|
0.92 |
|
0.92 |
|
0.88 |
||||||||||||||||||
Employees (December 31)1 |
|
176,486 |
|
193,865 |
|
188,876 |
|
185,827 |
|
178,140 |
||||||||||||||||||
|
||||||||||||||||||||||||||||